I'm not sure if I missed something but why has the
I'm not sure if I missed something but why has the sentiment turned so glass half empty? Nader has for the most part been late on his timelines, the company has always been short on cash and the drug is nothing but phenomenal. Expecting the OTC market to price value accurately is kind of naive, i don't understand why "the market" is being brought up at ll as some sort of factual value of this. Nothing has changed except this is moving forward and we are very close to the endzone that unlocks this. This company has always raised cash as needed and always had 1-2 million in the bank - which is great if you are an investor whom does not want to be diluted to nothing. The pressure to get this deal signed and finalized is odd - do you really think that this partner company just picks up their ball and goes home now? Small biotech's get deals done when there only in p2 with far less compelling drugs. We are in p3 with all the safety data to cover all other indications, do you really think some partner cant see the potential to make money off this within months (not years!) of signing this deal?
How is everyone just waking up realizing this is a very steep hill to climb? Why would any investor stick through far more risky time periods and chicken out now? The "market" is made up of a majority of note and warrant holders that are pros at making high risk into low risk investments while preserving their huge profit return potential. The retail investor is in the back seat providing this liquidity to keep it going, until, the huge world of investors realize what is here. Once one deal is signed, that partner will open up all other partnerships and the much larger investment world that will wash out the note and warrant holder risk mgmt strategy.
Nothing has changed! this is still an amazing drug - even if it was just a combo drug or even a GvHD drug! This company has raised $200 million to develop a drug that will generate 2-3x that in a few months once approved. What company can claim that, in any industry? There is no sign of a lack of confidence by mgmt, the BOD and all the Dr's researching this for a huge number of indications. Do you really want to look back at this 10 years from now and say you missed out on the drug that quite possibly will end HIV/Aids? This drug could likely end cancer metastasis for craps' sake!
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...
Continue Reading
Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...
Continue Reading
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...
Continue Reading
A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...
Continue Reading
Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...
Continue Reading
Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...
Continue Reading
A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...
Continue Reading
Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...
Continue Reading
Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...
Continue Reading
Top 5 Most Recently Viewed Articles
JPMorgan Adjusts Expectations for Maruti Suzuki Stock Recently, JPMorgan provided an updated perspective on Maruti Suzuki India Ltd (MSIL:IN), lowering its price target to ?12,160 from the previous ?13,275. The firm decided to keep a Neutral rating on the stock, reflecting its cautious approach amidst changing market dynamics. Financial Performance Highlights This...
Continue Reading
UnionPay Launches Payment Solutions for Apple Services UnionPay cardholders have exciting news! They can now seamlessly utilize their cards to pay for a variety of Apple services. This includes popular platforms such as the App Store, Apple Music, Apple TV, iCloud, and much more across selected regions. Expanding Global Reach In an announcement made recently, UnionPay...
Continue Reading
Atlas West's Innovative Approach to Housing Challenges Recently, the CEO of Atlas West, Daniel Shkolnik, addressed a gathering of nearly 400 industry insiders at the inaugural ADU conference, embracing an engaging discussion surrounding Accessory Dwelling Units (ADUs) and their pivotal role in addressing the housing crisis in urban areas. Key Highlights from the ADU Forum...
Continue Reading
Algebrik AI Partners with Carleton for Lending Innovation Algebrik AI Inc., an innovative player in the financial services technology sector, has recently announced a strategic partnership with Carleton, Inc. This collaboration brings forth a transformative approach to consumer lending, focusing on enhancing accuracy, compliance, and operational efficiency within the loan...
Continue Reading
Overview of Baxter International's Legal Situation Baxter International, Inc. (NYSE: BAX) has recently found itself at the center of a securities class action lawsuit. This lawsuit stems from serious allegations concerning its Novum IQ Large Volume Pump (Novum LVP), a device utilized for administering intravenous fluids that carry vital medications, blood products, and...
Continue Reading